TY - JOUR
KW - Adult
KW - Buprenorphine/administration & dosage
KW - Criminals/psychology
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Naloxone/administration & dosage
KW - office visits
KW - Opioid-Related Disorders/drug therapy/psychology
KW - Primary Health Care/methods
KW - Socioeconomic Factors
KW - Treatment Outcome
KW - Young Adult
AU - E. A. Wang
AU - B. A. Moore
AU - L. E. Sullivan
AU - D. A. Fiellin
A1 - 
AB - BACKGROUND: Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known. OBJECTIVE: The purpose of this study is to determine whether having a history of incarceration affects response to primary care office-based buprenorphine/naloxone treatment. DESIGN: In this post hoc secondary analysis of a randomized clinical trial, we compared demographic, clinical characteristics, and treatment outcomes among 166 participants receiving primary care office-based buprenorphine/naloxone treatment stratifying on history of incarceration. MAIN RESULTS: Participants with a history of incarceration have similar treatment outcomes with primary care office-based buprenorphine/naloxone than those without a history of incarceration (consecutive weeks of opioid-negative urine samples, 6.2 vs. 5.9, p = 0.43; treatment retention, 38% vs. 46%, p = 0.28). CONCLUSIONS: Prior history of incarceration does not appear to impact primary care office-based treatment of opioid dependence with buprenorphine/naloxone. Community health care providers can be reassured that initiating buprenorphine/naloxone in opioid dependent individuals with a history of incarceration will have similar outcomes as those without this history.
BT - Journal of general internal medicine
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 7
CY - United States
DO - 10.1007/s11606-010-1306-0
IS - 7
JF - Journal of general internal medicine
N2 - BACKGROUND: Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known. OBJECTIVE: The purpose of this study is to determine whether having a history of incarceration affects response to primary care office-based buprenorphine/naloxone treatment. DESIGN: In this post hoc secondary analysis of a randomized clinical trial, we compared demographic, clinical characteristics, and treatment outcomes among 166 participants receiving primary care office-based buprenorphine/naloxone treatment stratifying on history of incarceration. MAIN RESULTS: Participants with a history of incarceration have similar treatment outcomes with primary care office-based buprenorphine/naloxone than those without a history of incarceration (consecutive weeks of opioid-negative urine samples, 6.2 vs. 5.9, p = 0.43; treatment retention, 38% vs. 46%, p = 0.28). CONCLUSIONS: Prior history of incarceration does not appear to impact primary care office-based treatment of opioid dependence with buprenorphine/naloxone. Community health care providers can be reassured that initiating buprenorphine/naloxone in opioid dependent individuals with a history of incarceration will have similar outcomes as those without this history.
PP - United States
PY - 2010
SN - 1525-1497; 0884-8734
SP - 670
EP - 674
EP - 
T1 - Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone
T2 - Journal of general internal medicine
TI - Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 20213205
U3 - 10.1007/s11606-010-1306-0
VL - 25
VO - 1525-1497; 0884-8734
Y1 - 2010
ER -